"Compliance, Tolerance, and Efficacy of a Short Course of Chemoprophylaxis for Tuberculosis."

According to the authors' abstract of an article published in Medicina Clinica, "Objective: To evaluate compliance, side effects, and the efficacy of a short course of chemoprophylaxis for tuberculosis with isoniazid plus rifampin during 3 months, compared with the classic course of isoniazid for 9 months. Patients and Methods: Prospective, comparative, randomized, and open study of patients with the suitable criteria for chemoprophylaxis, in accordance with the guidelines of the U.S. Centers for Disease Control of 1990. Patients were divided into 2 groups: the group of isoniazid plus rifampin, received isoniazid (300 mg per day) plus rifampin (600 mg per day) for 3...

Want to see the full article?

• Purchase this article for only $3.00